taurine has been researched along with Primary Peritonitis in 32 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "We believe that peritoneal catheter taurolidine lock could be considered in cases of relapsing or refractory peritonitis, as it could prevent catheter removal and permanent switch to hemodialysis in selected cases, although literature is scarce and further studies are needed." | 8.02 | Relapsing peritonitis and taurolidine peritoneal catheter lock: One center experience. ( Álvarez Nadal, M; Burguera Vion, V; Campillo Trapero, C; Fernández Lucas, M; López Melero, E; Rivera Gorrín, ME; Sosa Barrios, RH, 2021) |
| "The higher bursting pressures and tissue hydroxyproline levels in the rats given taurolidine showed the positive effect of taurolidine on anastomotic strength in secondary peritonitis." | 7.73 | Effect of peritoneal lavage with taurolidine on primary colonic anastomosis in a rat model of secondary peritonitis. ( Akkuş, A; Barişik, NO; Bildik, N; Cevik, A; Gülmen, M; Oztürk, E; Sad, O, 2006) |
| "The aim of this study was to evaluate the influence of taurolidine (TAU) and polyhexanid (POLY) on basic inflammatory reactions during peritonitis by using an in vitro model of human peritoneum." | 7.71 | Influence of antiseptic agents on interleukin-8 release and transmigration of polymorphonuclear neutrophils in a human in vitro model of peritonitis. ( Mansouri, E; Schmitt-Graeff, A; Schöffel, U; Sendt, W; Wolff-Vorbeck, G, 2002) |
| "In 36 patients, intraoperative peritoneal lavage with PVP-iodine solution (26 patients) or with the iodine free chemotherapeutic agent Taurolin (10 patients) was performed because of peritonitis." | 7.67 | [Thyroid function after peritoneal lavage with polivinylpyrrolidone-iodine solution in diffuse peritonitis]. ( Görtz, G; Häring, R; Henckel, M; Meinhold, H, 1984) |
| "As secondary peritonitis is associated with a significant cytokine release that is compartementalized in the peritoneal cavity, taurolidine is bactericidal, antiendotoxic, and antiadherent locally and, on the other hand, may modulate the systemic cytokine-mediated inflammatory response after being adsorbed systemically by the peritoneum." | 6.40 | [Adjuvant therapy of peritonitis with taurolidine. Modulation of mediator liberation]. ( Staubach, KH, 1997) |
| "Taurolidine is a non-antibiotic antimicrobial, with broad bactericidal and fungicidal properties." | 5.37 | Unsuccessful application of taurolidine in the treatment of fungal peritonitis in peritoneal dialysis. ( Chiarelli, G; Cozzolino, M; Cusi, D; Gallieni, M; Olivi, L, 2011) |
| "We believe that peritoneal catheter taurolidine lock could be considered in cases of relapsing or refractory peritonitis, as it could prevent catheter removal and permanent switch to hemodialysis in selected cases, although literature is scarce and further studies are needed." | 4.02 | Relapsing peritonitis and taurolidine peritoneal catheter lock: One center experience. ( Álvarez Nadal, M; Burguera Vion, V; Campillo Trapero, C; Fernández Lucas, M; López Melero, E; Rivera Gorrín, ME; Sosa Barrios, RH, 2021) |
| "The higher bursting pressures and tissue hydroxyproline levels in the rats given taurolidine showed the positive effect of taurolidine on anastomotic strength in secondary peritonitis." | 3.73 | Effect of peritoneal lavage with taurolidine on primary colonic anastomosis in a rat model of secondary peritonitis. ( Akkuş, A; Barişik, NO; Bildik, N; Cevik, A; Gülmen, M; Oztürk, E; Sad, O, 2006) |
| "In this study, in an animal model of zymosan-induced peritonitis we have tested anti-inflammatory properties of Taurolidine (TRD), a synthetic derivative of taurine." | 3.73 | Anti-inflammatory effects of taurine derivatives (taurine chloramine, taurine bromamine, and taurolidine) are mediated by different mechanisms. ( Biedroń, R; Bobek, M; Kontny, E; Kurnyta, M; Marcinkiewicz, J; Maśliński, W, 2006) |
| "The aim of this study was to evaluate the influence of taurolidine (TAU) and polyhexanid (POLY) on basic inflammatory reactions during peritonitis by using an in vitro model of human peritoneum." | 3.71 | Influence of antiseptic agents on interleukin-8 release and transmigration of polymorphonuclear neutrophils in a human in vitro model of peritonitis. ( Mansouri, E; Schmitt-Graeff, A; Schöffel, U; Sendt, W; Wolff-Vorbeck, G, 2002) |
| "To assess the effect of debridement, intraoperative lavage with saline, and additional instillation of taurolidine or imipenem/cilastatin in rats with faecal peritonitis." | 3.70 | Local treatment of generalised peritonitis in rats; effects on bacteria, endotoxin and mortality. ( Bleichrodt, RP; Kooi, K; Rosman, C; Westerveld, GJ, 1999) |
| "In 36 patients, intraoperative peritoneal lavage with PVP-iodine solution (26 patients) or with the iodine free chemotherapeutic agent Taurolin (10 patients) was performed because of peritonitis." | 3.67 | [Thyroid function after peritoneal lavage with polivinylpyrrolidone-iodine solution in diffuse peritonitis]. ( Görtz, G; Häring, R; Henckel, M; Meinhold, H, 1984) |
| "As secondary peritonitis is associated with a significant cytokine release that is compartementalized in the peritoneal cavity, taurolidine is bactericidal, antiendotoxic, and antiadherent locally and, on the other hand, may modulate the systemic cytokine-mediated inflammatory response after being adsorbed systemically by the peritoneum." | 2.40 | [Adjuvant therapy of peritonitis with taurolidine. Modulation of mediator liberation]. ( Staubach, KH, 1997) |
| "Taurolidine is a non-antibiotic antimicrobial, with broad bactericidal and fungicidal properties." | 1.37 | Unsuccessful application of taurolidine in the treatment of fungal peritonitis in peritoneal dialysis. ( Chiarelli, G; Cozzolino, M; Cusi, D; Gallieni, M; Olivi, L, 2011) |
| "Taurolidine has bactericidal and antilipopolysaccharide properties." | 1.29 | Taurolidine, an antilipopolysaccharide agent, has immunoregulatory properties that are mediated by the amino acid taurine. ( Bouchier-Hayes, D; Mc Carthy, J; Redmond, HP; Watson, RW, 1995) |
| " However, by increasing the dosage of taurolin, survival is prolonged and mortality reduced." | 1.26 | The in vitro and in vivo activity of taurolin against anaerobic pathogenic organisms. ( Brodhage, H; Browne, MK; Leslie, GB; Pfirrman, RW, 1977) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 15 (46.88) | 18.7374 |
| 1990's | 9 (28.13) | 18.2507 |
| 2000's | 5 (15.63) | 29.6817 |
| 2010's | 2 (6.25) | 24.3611 |
| 2020's | 1 (3.13) | 2.80 |
| Authors | Studies |
|---|---|
| Sosa Barrios, RH | 1 |
| Álvarez Nadal, M | 1 |
| Burguera Vion, V | 1 |
| Campillo Trapero, C | 1 |
| López Melero, E | 1 |
| Fernández Lucas, M | 1 |
| Rivera Gorrín, ME | 1 |
| Kim, W | 1 |
| Kim, SH | 1 |
| Jang, JH | 1 |
| Kim, C | 1 |
| Kim, K | 1 |
| Suh, YG | 1 |
| Joe, Y | 1 |
| Chung, HT | 1 |
| Cha, YN | 1 |
| Surh, YJ | 1 |
| Branger, B | 1 |
| Marion, K | 1 |
| Bergeron, E | 1 |
| Perret, C | 1 |
| Zabadani, B | 1 |
| Reboul, P | 1 |
| Freney, J | 1 |
| Gallieni, M | 1 |
| Chiarelli, G | 1 |
| Olivi, L | 1 |
| Cozzolino, M | 1 |
| Cusi, D | 1 |
| Sendt, W | 1 |
| Mansouri, E | 1 |
| Schmitt-Graeff, A | 1 |
| Wolff-Vorbeck, G | 1 |
| Schöffel, U | 1 |
| Schneider, A | 1 |
| Sack, U | 1 |
| Rothe, K | 1 |
| Bennek, J | 1 |
| Akkuş, A | 1 |
| Gülmen, M | 1 |
| Cevik, A | 1 |
| Bildik, N | 1 |
| Sad, O | 1 |
| Oztürk, E | 1 |
| Barişik, NO | 1 |
| Marcinkiewicz, J | 1 |
| Kurnyta, M | 1 |
| Biedroń, R | 1 |
| Bobek, M | 1 |
| Kontny, E | 1 |
| Maśliński, W | 1 |
| Platt, J | 1 |
| Jones, RA | 1 |
| Bucknall, RA | 1 |
| Wesch, G | 3 |
| Petermann, C | 1 |
| Linder, MM | 3 |
| Görtz, G | 1 |
| Häring, R | 1 |
| Henckel, M | 1 |
| Meinhold, H | 1 |
| Marti, MC | 4 |
| Moser, G | 4 |
| Ott, W | 2 |
| Wicki, O | 3 |
| Browne, MK | 4 |
| Knight, BI | 1 |
| Skellern, GG | 1 |
| Pfirrmann, RW | 3 |
| Linder, M | 1 |
| del Ponte, F | 1 |
| Watson, RW | 1 |
| Redmond, HP | 1 |
| Mc Carthy, J | 1 |
| Bouchier-Hayes, D | 1 |
| Popović, M | 1 |
| Dugalni, D | 1 |
| Milićević, M | 1 |
| Petrović, M | 1 |
| Zuvela, M | 1 |
| Knezević, S | 1 |
| Janković, Z | 1 |
| Focht, J | 1 |
| Nösner, K | 1 |
| Reith, HB | 1 |
| Staubach, KH | 1 |
| Konukoglu, D | 1 |
| Iynem, H | 1 |
| Ziylan, E | 1 |
| Nagl, M | 1 |
| Hengster, P | 1 |
| Semenitz, E | 1 |
| Gottardi, W | 1 |
| Rosman, C | 1 |
| Westerveld, GJ | 1 |
| Kooi, K | 1 |
| Bleichrodt, RP | 1 |
| Vankemmel, M | 1 |
| Scherpereel, P | 1 |
| Leslie, GB | 1 |
| Pfirrman, RW | 1 |
| Brodhage, H | 1 |
| MacKenzie, M | 1 |
| Doyle, PJ | 1 |
| Billing, A | 1 |
| Fröhlich, D | 1 |
| Ruckdeschel, G | 1 |
| Hart, H | 1 |
| Seifert, J | 1 |
| Brendel, W | 1 |
2 reviews available for taurine and Primary Peritonitis
| Article | Year |
|---|---|
[Therapy of peritonitis today. Surgical management and adjuvant therapy strategies].
Topics: Anti-Infective Agents; Combined Modality Therapy; Humans; Peritoneal Lavage; Peritonitis; Surgical W | 1997 |
[Adjuvant therapy of peritonitis with taurolidine. Modulation of mediator liberation].
Topics: Anti-Infective Agents; Bacterial Infections; Combined Modality Therapy; Cytokines; Humans; Peritonit | 1997 |
7 trials available for taurine and Primary Peritonitis
| Article | Year |
|---|---|
Peritoneal taurolidine lavage in children with localised peritonitis due to appendicitis.
Topics: Anti-Infective Agents; Appendicitis; Child; Female; Humans; Male; Peritonitis; Receptors, Interleuki | 2005 |
[Drug therapy of peritonitis. 6-year experience with the chemotherapeutic agent and anti-endotoxin taurolin].
Topics: Anti-Bacterial Agents; Clinical Trials as Topic; Double-Blind Method; Drainage; Humans; Infusions, P | 1983 |
[Appendicular peritonitis: comparative study of antibiotic therapy and a topical bactericidal agent].
Topics: Administration, Topical; Ampicillin; Anti-Infective Agents; Appendicitis; Clindamycin; Humans; Injec | 1980 |
[Antibacterial therapy of purulent peritonitis: a prospective randomized study on the effects of antibiotics and taurolin, a new chemotherapeutic and antiendotoxic agent (author's transl)].
Topics: Anti-Bacterial Agents; Bacterial Infections; Drug Therapy, Combination; Endotoxins; Female; Humans; | 1980 |
[Therapy of peritonitis today. Surgical management and adjuvant therapy strategies].
Topics: Anti-Infective Agents; Combined Modality Therapy; Humans; Peritoneal Lavage; Peritonitis; Surgical W | 1997 |
[Tauroline in peritonitis].
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Bacteria; Biotransformation; Clinical Trials | 1979 |
C controlled trial of taurolin in established bacterial peritonitis.
Topics: Adolescent; Adult; Aged; Anti-Infective Agents, Local; Bacterial Infections; Child; Clinical Trials | 1978 |
24 other studies available for taurine and Primary Peritonitis
| Article | Year |
|---|---|
Relapsing peritonitis and taurolidine peritoneal catheter lock: One center experience.
Topics: Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Catheter-Related Infections; Catheterization; | 2021 |
Role of heme oxygenase-1 in potentiation of phagocytic activity of macrophages by taurine chloramine: Implications for the resolution of zymosan A-induced murine peritonitis.
Topics: Animals; Antioxidants; Heme Oxygenase-1; Inflammation; Macrophages; Macrophages, Peritoneal; Mice; M | 2018 |
Using detachment-promoting agents for the prevention of chronic peritoneal dialysis-associated infections.
Topics: Anti-Infective Agents; Bacterial Adhesion; Biofilms; Catheter-Related Infections; Catheters, Indwell | 2008 |
Unsuccessful application of taurolidine in the treatment of fungal peritonitis in peritoneal dialysis.
Topics: Adult; Antifungal Agents; Candidiasis; Catheter-Related Infections; Catheters, Indwelling; Device Re | 2011 |
Influence of antiseptic agents on interleukin-8 release and transmigration of polymorphonuclear neutrophils in a human in vitro model of peritonitis.
Topics: Anti-Infective Agents, Local; Anti-Inflammatory Agents; Biguanides; Cell Movement; Dose-Response Rel | 2002 |
Effect of peritoneal lavage with taurolidine on primary colonic anastomosis in a rat model of secondary peritonitis.
Topics: Anastomosis, Surgical; Animals; Anti-Infective Agents, Local; Colon; Disease Models, Animal; Female; | 2006 |
Anti-inflammatory effects of taurine derivatives (taurine chloramine, taurine bromamine, and taurolidine) are mediated by different mechanisms.
Topics: Animals; Anti-Inflammatory Agents; Cells, Cultured; Chloramines; Enzyme Induction; Heme Oxygenase-1; | 2006 |
Intraperitoneal antiseptics in experimental bacterial peritonitis.
Topics: Animals; Anti-Infective Agents, Local; Chlorhexidine; Disease Models, Animal; Escherichia coli Infec | 1984 |
[Thyroid function after peritoneal lavage with polivinylpyrrolidone-iodine solution in diffuse peritonitis].
Topics: Adult; Humans; Iodine; Peritoneal Cavity; Peritonitis; Povidone; Povidone-Iodine; Taurine; Therapeut | 1984 |
[Therapy of purulent peritonitis. Documentation of 78 cases and experience with taurolin (author's transl)].
Topics: Adult; Chemical Phenomena; Chemistry; Humans; Middle Aged; Peritonitis; Postoperative Period; Taurin | 1981 |
The treatment of peritonitis by an antiseptic - taurolin.
Topics: Adolescent; Adult; Aged; Anti-Infective Agents, Local; Appendicitis; Child; Child, Preschool; Endoto | 1981 |
Peritoneal absorption of the antibacterial and antiendotoxin taurolin in peritonitis.
Topics: Absorption; Adult; Anti-Bacterial Agents; Bacteria; Female; Humans; Male; Middle Aged; Peritoneum; P | 1981 |
[Intravenous and intraperitoneal administration of an antiseptic: 65 cases of diffuse peritonitis treated with taurolin].
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Female; Humans; Injections, Intraperitoneal; Injecti | 1980 |
Taurolidine, an antilipopolysaccharide agent, has immunoregulatory properties that are mediated by the amino acid taurine.
Topics: Animals; Calcium; Female; Macrophage-1 Antigen; Macrophages, Peritoneal; Mice; Nitric Oxide; Periton | 1995 |
[Use of taurolin in the prevention of septic complications in emergency abdominal surgery].
Topics: Abdomen; Anti-Infective Agents; Bacterial Infections; Emergencies; Humans; Intraoperative Care; Peri | 1991 |
[1996 pathogen incidence and resistance status in peritonitis].
Topics: Anti-Bacterial Agents; Bacterial Infections; Drug Resistance, Microbial; Humans; Microbial Sensitivi | 1997 |
Antioxidant status in experimental peritonitis: effects of alpha tocopherol and taurolin.
Topics: Animals; Anti-Infective Agents; Antioxidants; Disease Models, Animal; Glutathione; Glutathione Perox | 1999 |
The postantibiotic effect of N-chlorotaurine on Staphylococcus aureus. Application in the mouse peritonitis model.
Topics: Analysis of Variance; Animals; Anti-Bacterial Agents; Disease Models, Animal; Mice; Peritonitis; Sta | 1999 |
Local treatment of generalised peritonitis in rats; effects on bacteria, endotoxin and mortality.
Topics: Abdominal Abscess; Animals; Anti-Infective Agents, Local; Cilastatin; Debridement; Drug Combinations | 1999 |
[Focalized irrigation-lavage and sequential use of a new antiseptic by local and general route. Preliminary report apropos of 2 cases of suppurative pancreatic necrosis].
Topics: Administration, Topical; Adult; Aged; Anti-Inflammatory Agents; Drug Tolerance; Female; Humans; Inje | 1978 |
The in vitro and in vivo activity of taurolin against anaerobic pathogenic organisms.
Topics: Animals; Bacterial Infections; Bacteroides; Bacteroides Infections; Clostridium Infections; Clostrid | 1977 |
[Intraperitoneal and intravenous tauroflex, without antibiotics in the treatment of 40 cases of peritonitis (author's transl)].
Topics: Anti-Infective Agents; Female; Humans; Male; Middle Aged; Peritonitis; Taurine; Thiadiazines; Thiazi | 1978 |
[The effect of taurolin on endogenous immunity and pathogen elimination in human peritonitis].
Topics: Aged; Aged, 80 and over; Anti-Infective Agents, Local; Bacterial Infections; Colony Count, Microbial | 1992 |
[Effects and side effects of taurolin in experimental peritonitis in the rat].
Topics: Animals; Anti-Bacterial Agents; Drug Therapy, Combination; Gentamicins; Male; Peritonitis; Piperacil | 1986 |